Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (45)
Marnie Slonim, Michelle Peate, Kira Merigan, Daniel Lantsberg, Richard A. Anderson, Kate Stern, Debra Gook & Yasmin Jayasinghe. (2023) Ovarian stimulation and oocyte cryopreservation in females and transgender males aged 18 years or less: a systematic review. Frontiers in Endocrinology 14.
Crossref
Crossref
Oren Kashi, Hadassa Roness, Itai Spector, Sanaz Derech-Haim & Dror Meirow. (2023) Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve. Human Reproduction 38:6, pages 1086-1098.
Crossref
Crossref
Ahmed Sabry S. Abdoon, Ahmed M.E Al-Atrash, Seham S. Soliman, Amro M. El-Sanea, Amina A. Gamal el Din & Hossam M. Fahmy. (2023) Lyophilized equine platelet-rich plasma (L-GFequina) antagonize the Reproductive toxicity and oxidative stress Induced by Cyclophosphamide in female rats. Journal of Ovarian Research 16:1.
Crossref
Crossref
Zhipeng Fan, Hongfei Song, Rongli Yuan, Yangzhi Peng & Yong Jiang. (2023) Genetic predisposition to female infertility in relation to epithelial ovarian and endometrial cancers. Postgraduate Medical Journal 99:1168, pages 63-68.
Crossref
Crossref
M Salama, L. Nahata, Y. Jayasinghe, V. Gomez-Lobo, MM. Laronda, MB. Moravek, LR. Meacham, MS. Christianson, M. Lambertini, A. Anazodo, GP. Quinn & TK. Woodruff. (2022) Pediatric oncofertility care in limited versus optimum resource settings: results from 39 surveyed centers in Repro-Can-OPEN Study Part I & II. Journal of Assisted Reproduction and Genetics 40:3, pages 443-454.
Crossref
Crossref
Yue Xiao, Yue Peng, Chi Zhang, Wei Liu, Kehan Wang & Jing Li. (2023) hucMSC-derived exosomes protect ovarian reserve and restore ovarian function in cisplatin treated mice. The Journal of Biomedical Research 37:3, pages 1.
Crossref
Crossref
Silvia Inés Ciarmatori & Rey Valzacchi Gaston. (2022) Freezing techniques as fertility preservation strategies: a narrative review. Obstetrics & Gynecology International Journal 13:6, pages 395-400.
Crossref
Crossref
Fen Xing, Mengyao Wang, Zhiming Ding, Junhui Zhang, Simin Ding, Lingge Shi, Qinge Xie, Muhammad Jamil Ahmad, Zhaolian Wei, Liang Tang, Dan Liang, Yunxia Cao & Yajing Liu. (2022) Protective Effect and Mechanism of Melatonin on Cisplatin-Induced Ovarian Damage in Mice. Journal of Clinical Medicine 11:24, pages 7383.
Crossref
Crossref
Richard A. Anderson, Matteo Lambertini, Peter S. Hall, W. Hamish Wallace, David S. Morrison & Tom W. Kelsey. (2022) Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy. European Journal of Cancer 173, pages 113-122.
Crossref
Crossref
Raffaella Cioffi, Maria Luisa Fais, Alice Bergamini, Valeria Stella Vanni, Luca Pagliardini, Enrico Papaleo, Giorgia Mangili & Massimo Candiani. (2022) Ovarian failure risk in post-pubertal patients with cancer: a prognostic model. Future Oncology 18:19, pages 2391-2400.
Crossref
Crossref
Francisco Denilson Rodrigues Gomes, Danielle Cristina Calado de Brito, Naíza Arcângela Ribeiro de Sá, Lucy Vanessa Sulca Ñaupas, Gaby Judith Quispe Palomino, Renato Felix da Silva, Éverton Pimentel Ferreira Lopes, Gildas Tetaping Mbemya, Benner Geraldo Alves, Mary Zelinski, José Ricardo de Figueiredo & Ana Paula Ribeiro Rodrigues. (2021) Development of sheep secondary follicles and preservation of aromatase and metalloproteinases 2 and 9 after vitrification and in vitro culture. Cell and Tissue Banking 23:2, pages 247-259.
Crossref
Crossref
Chiara Di Tucci, Giulia Galati, Giulia Mattei, Alessandra Chinè, Alice Fracassi & Ludovico Muzii. (2022) Fertility after Cancer: Risks and Successes. Cancers 14:10, pages 2500.
Crossref
Crossref
Richard A Anderson, David Cameron, Florian Clatot, Isabelle Demeestere, Matteo Lambertini, Scott M Nelson & Fedro Peccatori. (2022) Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Human Reproduction Update 28:3, pages 417-434.
Crossref
Crossref
Dóra Vesztergom, Gyöngyvér Téglás, László Nánássy, Zoltán Mátrai & Zoltán Novák. (2022) A termékenység megőrzése daganatos betegségekben.. Orvosi Hetilap 163:6, pages 246-252.
Crossref
Crossref
Richard A. Anderson, Tom W. Kelsey, David S. Morrison & W. Hamish B. Wallace. (2022) Family size and duration of fertility in female cancer survivors: a population-based analysis. Fertility and Sterility 117:2, pages 387-395.
Crossref
Crossref
S. Caprioli, T. W. Kelsey & W. H. B. Wallace. 2022. Female and Male Fertility Preservation. Female and Male Fertility Preservation
35
45
.
Tom G. Tanbo & Peter Z. Fedorcsak. (2021) Can time to menopause be predicted?. Acta Obstetricia et Gynecologica Scandinavica 100:11, pages 1961-1968.
Crossref
Crossref
Lesley Stafford, Michelle Sinclair, Katrin Gerber, Leah Collins, Louise Newman, Christobel Saunders, Angela Ives, Kylie D. Mason, Michelle Peate, Jocelyn Lippey, Mark P. Umstad, Kerry Shanahan & Ruth Little. (2021) Cancer during pregnancy: A qualitative study of healthcare experiences of Australian women. European Journal of Cancer Care 30:4.
Crossref
Crossref
Khadija Kacem Berjeb, Linda Debbabi, Marouen Braham, Zeineb Zemni, Sana Chtourou, Hela Hannachi, Manel Hamdoun, Mouna Ayadi, Karima Kacem, Fethi Zhioua, Anis Fadhlaoui, Olfa Bahri & Nozha Chakroun. (2021) Evaluation of ovarian reserve before and after chemotherapy. Journal of Gynecology Obstetrics and Human Reproduction 50:5, pages 102035.
Crossref
Crossref
Richard A Anderson & Rod T Mitchell. 2021. Fertility Preservation. Fertility Preservation
25
34
.
Maya Chetty & Richard A. Anderson. 2021. Reproductive Medicine for the MRCOG. Reproductive Medicine for the MRCOG
113
122
.
Richard A. Anderson, Florian Clatot, Isabelle Demeestere, Matteo Lambertini, Adrienne Morgan, Scott M. Nelson, Fedro Peccatori & David Cameron. (2021) Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessments. European Journal of Cancer 144, pages 310-316.
Crossref
Crossref
M. Vatel, A. Torre, B. Paillusson, F. Scheffler, M. Bergere, M. Benkhalifa, M.-T. Le Martelot, F. Leperlier, S. Mirallié, L. Selleret, M. Prades-Borio, A. Neuraz, V. Barraud-Lange, N. Boissel, A. Fortin & C. Poirot. (2021) Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors. Journal of Assisted Reproduction and Genetics 38:2, pages 503-511.
Crossref
Crossref
Stephanie da Silva, Renata Boer, Lóris Aparecida Prado da Cruz & Thais de Oliveira Gozzo. (2021) Fertilidade e contracepção em mulheres com câncer em tratamento quimioterápico. Escola Anna Nery 25:1.
Crossref
Crossref
. (2021) Installing oncofertility programs for common cancers in optimum resource settings (Repro-Can-OPEN Study Part II): a committee opinion. Journal of Assisted Reproduction and Genetics 38:1, pages 163-176.
Crossref
Crossref
MEREDITH HUMPHREYS, ERICA JOHNSTONE & JOSEPH M. LETOURNEAU. (2020) Current Approaches to Fertility Preservation. Clinical Obstetrics & Gynecology 63:4, pages 735-751.
Crossref
Crossref
Richard A. Anderson & Scott M. Nelson. (2021) Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insufficiency. Seminars in Reproductive Medicine 38:04/05, pages 263-269.
Crossref
Crossref
Daniela Rebhan. (2020) AMH – Ovarreserve nach onkologischen ErkrankungenL’hormone de régression müllérienne: réserve ovarienne à la suite de maladies oncologiques. Journal für Gynäkologische Endokrinologie/Schweiz 23:3, pages 103-110.
Crossref
Crossref
Richard A Anderson & W Hamish B Wallace. (2020) The Use of AMH to Assess Ovarian Toxicity in Adolescents and Young Adults After Cancer Treatment. The Journal of Clinical Endocrinology & Metabolism 105:8, pages e3006-e3007.
Crossref
Crossref
Renée M.G. Verdiesen, Carla H. van Gils, Yvonne T. van der Schouw & N. Charlotte Onland-Moret. (2020) Anti-Müllerian hormone levels and risk of cancer: A systematic review. Maturitas 135, pages 53-67.
Crossref
Crossref
Pinar Ozcan, Taha Takmaz, Olgu Enis Tok, Sevde Islek, Esra Nur Yigit & Cem Ficicioglu. (2020) The protective effect of platelet-rich plasma administrated on ovarian function in female rats with Cy-induced ovarian damage. Journal of Assisted Reproduction and Genetics 37:4, pages 865-873.
Crossref
Crossref
Zobaida Edib, Yasmin Jayasinghe, Martha Hickey, Lesley Stafford, Richard A Anderson, H. Irene Su, Kate Stern, Christobel Saunders, Antoinette Anazodo, Mary Macheras-Magias, Shanton Chang, Patrick Pang, Franca Agresta, Laura Chin-Lenn, Wanyuan Cui, Sarah Pratt, Alex Gorelik & Michelle Peate. (2020) Exploring the facilitators and barriers to using an online infertility risk prediction tool (FoRECAsT) for young women with breast cancer: a qualitative study protocol. BMJ Open 10:2, pages e033669.
Crossref
Crossref
Y. Wang, Shanna Logan, K. Stern, C. E. Wakefield, R. J. Cohn, F. Agresta, Y. Jayasinghe, R. Deans, E. Segelov, R. I. McLachlan, B. Gerstl, E. Sullivan, W. E. Ledger & A. Anazodo. (2019) Supportive oncofertility care, psychological health and reproductive concerns: a qualitative study. Supportive Care in Cancer 28:2, pages 809-817.
Crossref
Crossref
Rafaella Araújo Correia, Cristine Vieira do Bonfim, Kéllida Moreira Alves Feitosa, Betise Mery Alencar Sousa Macau Furtado, Daniela Karina da Silva Ferreira & Solange Laurentino dos Santos. (2020) Disfunção sexual após tratamento para o câncer do colo do útero. Revista da Escola de Enfermagem da USP 54.
Crossref
Crossref
Joseph Letourneau & Douglas Fair. (2020) Oncofertility in urologic oncology: Fertility preservation for women undergoing cancer treatment. Urologic Oncology: Seminars and Original Investigations 38:1, pages 14-22.
Crossref
Crossref
N Spears, F Lopes, A Stefansdottir, V Rossi, M De Felici, R A Anderson & F G Klinger. (2019) Ovarian damage from chemotherapy and current approaches to its protection. Human Reproduction Update 25:6, pages 673-693.
Crossref
Crossref
Zhi-Ming Ding, Shou-Xin Zhang, Xiao-Fei Jiao, Li-Ping Hua, Muhammad Jamil Ahmad, Di Wu, Fan Chen, Yong-Shang Wang, Xi-Yu Zhang, Fei Meng, Ze-Qun Duan, Yi-Liang Miao & Li-Jun Huo. (2019) Doxorubicin Exposure Affects Oocyte Meiotic Maturation through DNA Damage-Induced Meiotic Arrest. Toxicological Sciences 171:2, pages 359-368.
Crossref
Crossref
K.E. Palinska-Rudzka, T. Ghobara, N. Parsons, J. Milner, G. Lockwood & G.M. Hartshorne. (2019) Five-year study assessing the clinical utility of anti-Müllerian hormone measurements in reproductive-age women with cancer. Reproductive BioMedicine Online 39:4, pages 712-720.
Crossref
Crossref
Giovanna Bellusci, Luca Mattiello, Valentina Iannizzotto, Sarah Ciccone, Emiliano Maiani, Valentina Villani, Marc Diederich & Stefania Gonfloni. (2019) Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility. Cell Death & Disease 10:10.
Crossref
Crossref
H. Roness, I. Spector, Y. Leichtmann-Bardoogo, A. M. Savino, Sanaz Dereh-Haim & Dror Meirow. (2019) Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects. Journal of Assisted Reproduction and Genetics 36:9, pages 1793-1803.
Crossref
Crossref
Asmahane Ladjouze & Malcolm Donaldson. (2019) Primary gonadal failure. Best Practice & Research Clinical Endocrinology & Metabolism 33:3, pages 101295.
Crossref
Crossref
Marian A. Spath & Didi D.M. Braat. (2019) Iatrogenic and non‐iatrogenic causes of female fertility loss that may indicate fertility preservation. Acta Obstetricia et Gynecologica Scandinavica 98:5, pages 559-562.
Crossref
Crossref
Hanneke M. van Santen, Marry M. van den Heuvel-Eibrink, Marianne D. van de Wetering & W. Hamish Wallace. (2019) Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up. Hormone Research in Paediatrics 91:2, pages 93-103.
Crossref
Crossref
Queenie Ho Yan Wong & Richard A. Anderson. (2018) The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery. Current Opinion in Endocrinology & Diabetes and Obesity 25:6, pages 391-398.
Crossref
Crossref
Richard A Anderson, Rachel Remedios, Amy A Kirkwood, Pip Patrick, Linsey Stevens, Laura Clifton-Hadley, Tom Roberts, Chris Hatton, Nagesh Kalakonda, Don W Milligan, Pam McKay, Clare Rowntree, Fiona M Scott & Peter W M Johnson. (2018) Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial. The Lancet Oncology 19:10, pages 1328-1337.
Crossref
Crossref